China Shineway(2877: HK): Beneficiary from Deregulation of Non-Essential Drug in Grassroots Level
A year ago, I wrote about China Shineway Pharmaceutical Group Ltd. (2877 HK) that has a couple of low-cost drugs that sell in the second and third...
464 Views
Energy Medicine. Personal Experience. Impact. Growth in Asia. Ideas
This is an invest-able idea at the private level with long term benefits. Both for the body, and for other ideas as well.Ever since I turned over...
3.8k Views
TaiGen Sold Its Furaprevir for 25x of Market Capital
Summary What's new? Taigen and HEC Pharm announced a new joint venture. HEC Pharm agrees Taigen to use its developed new drug Furaprevir...
305 Views
HEC ChangJiang Pharma IPO - Just a Manufacturing Shell
YiChang HEC ChangJiang Pharmaceuticals (YHCP) plans to raise US$160-215m through an issuance of primary shares in its IPO.We've worked along...
372 Views
Can Innovation labs be assessed to pick stocks for your portfolio?
Companies across different industries are building Innovation centers in Singapore, Hong Kong and other cities across Asia and the rest of the...
679 Views